Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice

Cancer Cell

Volumn 11, Issue 3, 2007, Pages 291-302

  Guerra, Carmen ^a   Schuhmacher, Alberto J ^a   Cañamero, Marta ^a   Grippo, Paul J ^b   Verdaguer, Lena ^a   Pérez Gallego, Lucía ^a   Dubus, Pierre ^c   Sandgren, Eric P ^d   Barbacid, Mariano ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CELLCYCLE

Indexed keywords

ACINAR CELL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CHRONIC PANCREATITIS; EMBRYO; EMBRYO CELL; GENE EXPRESSION; GENE MUTATION; GENETICS; INVASIVE CARCINOMA; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL; SOMATIC MUTATION; TISSUE INJURY;

MUS;

EID: 33847419143     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.01.012     Document Type: Article

References (44)

1. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., and DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17 (2003) 3112-3126
2. Almoguera C., Shibata D., Forrester K., Martin J., Arnheim N., and Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 (1988) 549-554
3. Bardeesy N., Cheng K.H., Berger J.H., Chu G.C., Pahler J., Olson P., Hezel A.F., Horner J., Lauwers G.Y., Hanahan D., and Depinho R.A. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20 (2006) 3130-3146
4. Bartek T., Bartkova J., Vojtesek B., Staskova Z., Lukas J., Rejthar A., Kovarik J., Midley C.A., Gannon J.V., and Lane D. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6 (1991) 1699-1703
5. Brembeck F.H., Schreiber F.S., Deramaudt T.B., Craig L., Rhoades B., Swain G., Grippo P., Stoffers D.A., Silberg D.G., and Rustgi A.K. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63 (2003) 2005-2009
6. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
7. Furth P.A., St Onge L., Boger H., Gruss P., Gossen M., Kistner A., Bujard H., and Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91 (1994) 9302-9306
8. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., and Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
9. Grippo P.J., Nowlin P.S., Demeure M.J., Longnecker D.S., and Sandgren E.P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 63 (2003) 2016-2019
10. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4 (2003) 111-120
11. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4 (2003) 437-450
12. Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., Rustgi A.K., Chang S., and Tuveson D.A. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7 (2005) 469-483
13. Hruban R.H., Wilentz R.E., and Kern S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156 (2000) 1821-1825
14. Hruban R.H., Wilentz R.E., and Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol. Med. 103 (2005) 1-13
15. Hruban R.H., Adsay N.V., Albores-Saavedra J., Anver M.R., Biankin A.V., Boivin G.P., Furth E.E., Furukawa T., Klein A., Klimstra D.S., et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 66 (2006) 95-106
16. Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Fujitani Y., Fujitani S., Wright C.V., and Moses H.L. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev. 20 (2006) 3147-3160
17. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., and Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15 (2001) 3243-3248
18. Joyce A.D., D'Emilia J.C., Steele Jr. G., Libertino J.A., Silverman M.L., and Summerhayes I.C. Detection of altered H-ras proteins in human tumors using western blot analysis. Lab. Invest. 61 (1989) 212-218
19. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
20. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
21. Kawaguchi Y., Cooper B., Gannon M., Ray M., MacDonald R.J., and Wright C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32 (2002) 128-134
22. Kern S.E. Molecular genetic alterations in ductal pancreatic adenocarcinomas. Med. Clin. North Am. 84 (2000) 691-695
23. Kim S.K., and MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev. 12 (2002) 540-547
24. Kimura W., Morikane K., Esaki Y., Chung W.C., and Pour P.M. Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy. Cancer 82 (1998) 1839-1849
25. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., Dimagno E.P., Andren-Sandberg A., and Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 328 (1993) 1433-1437
26. Maeda S., Kamata H., Luo J.L., Leffert H., and Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005) 977-990
27. Maitra A., Fukushima N., Takaori K., and Hruban R.H. Precursors to invasive pancreatic cancer. Adv. Anat. Pathol. 12 (2005) 81-91
28. Malka D., Hammel P., Maire F., Rufat P., Madeira I., Pessione F., Levy P., and Ruszniewski P. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (2002) 849-852
29. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., Sriuranpong V., Iso T., Meszoely I.M., Wolfe M.S., et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3 (2003) 565-576
30. Mountford P., Zevnik B., Duwel A., Nichols J., Li M., Dani C., Robertson M., Chambers I., and Smith A. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 91 (1994) 4303-4307
31. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., Hogan B.L., and Wright C.V. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122 (1996) 983-995
32. Ornitz D.M., Hammer R.E., Davison B.L., Brinster R.L., and Palmiter R.D. Promoter and enhancer elements from the rat elastase I gene function independently of each other and of heterologous enhancers. Mol. Cell. Biol. 7 (1987) 3466-3472
33. Pasca di Magliano M., Sekine S., Ermilov A., Ferris J., Dlugosz A.A., and Hebrok M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 20 (2006) 3161-3173
34. Quaife C.J., Pinkert C.A., Ornitz D.M., Palmiter R.D., and Brinster R.L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48 (1987) 1023-1034
35. Saam J.R., and Gordon J.I. Inducible Gene Knockouts in the Small Intestinal and Colonic Epithelium. J. Biol. Chem. 274 (1999) 38071-38082
36. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70-71
37. Stanger B.Z., Stiles B., Lauwers G.Y., Bardeesy N., Mendoza M., Wang Y., Greenwood A., Cheng K.H., McLaughlin M., Brown D., et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8 (2005) 185-195
38. Steinle A.U., Weidenbach H., Wagner M., Adler G., and Schmid R.M. NF-κB/Rel Activation in cerulein pancreatitis. Gastroenterology 116 (1999) 420-430
39. Tezel E., Nagasaka T., Nomoto S., Sugimoto H., and Nakao A. Neuroendocrine-like differentiation in patients with pancreatic carcinoma. Cancer 89 (2000) 2230-2236
40. Tuveson D.A., and Hingorani S.R. Ductal pancreatic cancer in humans and mice. Cold Spring Harb. Symp. Quant. Biol. 70 (2005) 65-72
41. Tuveson D.A., Zhu L., Gopinathan A., Willis N.A., Kachatrian L., Grochow R., Pin C.L., Mitin N.Y., Taparowsky E.J., Gimotty P.A., et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res. 66 (2006) 242-247
42. Whitcomb D.C., and Pogue-Geile K. Pancreatitis as a risk for pancreatic cancer. Gastroenterol. Clin. North Am. 31 (2002) 663-678
43. Willemer S., Elsasser H.P., and Adler G. Hormone-induced pancreatitis. Eur. Surg. Res. 24 (1992) 29-39
44. Yoo B.M., Oh T.Y., Kim Y.B., Yeo M., Lee J.S., Surh Y.J., Ahn B.O., Kim W.H., Sohn S., Kim J.H., et al. Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatol. 5 (2005) 165-176